Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12016-013-8404-9
DC FieldValue
dc.titleA Comprehensive Review of Sensitization and Allergy to Soy-Based Products
dc.contributor.authorKatz, Y.
dc.contributor.authorGutierrez-Castrellon, P.
dc.contributor.authorGonzález, M.G.
dc.contributor.authorRivas, R.
dc.contributor.authorLee, B.W.
dc.contributor.authorAlarcon, P.
dc.date.accessioned2016-07-08T07:19:33Z
dc.date.available2016-07-08T07:19:33Z
dc.date.issued2014
dc.identifier.citationKatz, Y., Gutierrez-Castrellon, P., González, M.G., Rivas, R., Lee, B.W., Alarcon, P. (2014). A Comprehensive Review of Sensitization and Allergy to Soy-Based Products. Clinical Reviews in Allergy and Immunology : 1-10. ScholarBank@NUS Repository. https://doi.org/10.1007/s12016-013-8404-9
dc.identifier.issn10800549
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/125284
dc.description.abstractSince 1943, cases of sensitization or allergy to soy-based formulas (SBFs) have been described without any consensus on their real prevalence. We identified the adjusted prevalence of IgE-mediated soy allergies in children and performed a secondary analysis of the impact of age (less than and more than 6 months). We performed a systematic review with meta-analysis of studies published from 1909 to 2013 in PubMed, Embase, LILACS, ARTEMISA, Cochrane, Bandolier, DARE and the GRADE system for grading quality. Results are presented in tables and graphs using a forest plot. The 40 studies identified established weighted prevalence of soy allergies of 0 to 0.5 % (0.27) for the general population, 0.4 to 3.1 % (1.9) for the referred population, and 0 to 12.9 % (2.7) for allergic children. Prevalence of sensitization after the use of SBFs is 8.7 and 8.8 %, depending on the method used. The prevalence of allergies to soy and IgE sensitization to the use of SBFs is less than reported. Not enough evidence exists to show a higher risk of allergy in infants younger than 6 months. The concern about soy allergy is no reason to postpone the use of SBFs in IgE-mediated cow's milk allergy infants until the age of 6 months. © 2014 Springer Science+Business Media New York.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s12016-013-8404-9
dc.sourceScopus
dc.subjectAllergy
dc.subjectCow's milk allergy
dc.subjectIgE
dc.subjectInfant formula
dc.subjectSoy
dc.subjectSoy allergy
dc.typeArticle
dc.contributor.departmentPAEDIATRICS
dc.description.doi10.1007/s12016-013-8404-9
dc.description.sourcetitleClinical Reviews in Allergy and Immunology
dc.description.page1-10
dc.description.codenCRVAD
dc.identifier.isiut000335153100009
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

37
checked on Jul 9, 2020

WEB OF SCIENCETM
Citations

32
checked on Jul 9, 2020

Page view(s)

104
checked on Jul 11, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.